scholarly journals Korelasi Positif Perubahan Berat Badan Interdialisis dengan Perubahan Tekanan Darah Pasien Post Hemodialisa

2016 ◽  
Vol 2 (1) ◽  
pp. 1
Author(s):  
Purnomo Widiyanto ◽  
Hamam Hadi ◽  
Teguh Wibowo

<p>Interdialysis body weight is used to determine ultra fi ltration speed on hemodialisa patients. The overload ultra fi ltration can infl uence patients hemodynamic. According to Renal Registry Indonesia, it was 11 percent in 2012 dialysis patients experienced hypotension. This observational analytic study used cohort survey aims to analyse changing of interdialysis body weight and of blood pressure among dialysis patients in RSUD Saras Husada Purworejo. In this research, 40 respondents divided into two groups by purposive sampling based on inclusion and exclusion criteria. Data was analysed using Paired T-Test, Spearman Rank Test and Chi Square and was obtained characteristics subject sexes p= 0.736, p= 0.744 age, history of diabetes p=0.311 and p= 0.185 HT history means that there were no signifi cant correlation with the increase interdialisis BB. (p&gt;0.05). Correlation interdialisis BB with changing in BP, RR=2,750 x²= 3.84 and p= 0.050 (p= 0.050) was signifi cantly in positive direction. Conclusion, there was correlation between interdialysis body weight changing with blood pressure elevation. 8% of those who exposed the rise interdialysis body weight was hypotension.</p>

2021 ◽  
Vol 5 (2) ◽  
pp. 087-095
Author(s):  
Mbula MMK ◽  
Longo-Mbenza B ◽  
Situakibanza HNT ◽  
Mananga GL ◽  
Makulo JRR ◽  
...  

Background: The survival of people living with HIV (PLWHIVs) is increased and Health systems will have to deal with the early-aging-associated medical conditions. Objective: The objective of this study is to compare the clinical and biological profiles of PLWHIVs aged 50 and over and those aged less than 50 years. Material and methods: This study conducted at Kinshasa University Teaching Hospital (KUTH) covers 6 years. The clinical and biological characteristics of PLWHIVs aged 50 and over were compared with those under 50. Statistical analysis used the means ± SD, the calculation of frequencies, Student’s t-test and Chi-square. Results: PLWHIVs aged 50 or over represented 35.1%. Their average age was 58.0 ± 4.8 years. Women predominate among those under 50 and men among those 50 and over. Married people were more numerous (54% among those under 50). There were more unemployed (50% of PLHIV under 50). Patients 50 years and older were significantly classified as WHO stage 4 with a high frequency of history of tuberculosis, genital herpes, high blood pressure, smoking, vomiting, hepatomegaly, moderate elevation of diastolic blood pressure (DBP) and sytolic blood pressure (SBP), tuberculosis and anemia. Those under 50 had a significantly increased frequency of shingles, hepatitis B-hepatitis C, headaches and more survivals. The mean of Hb, HDL-C, and CD4s+ were significantly lower in patients 50 years and older, and urea, LDL-C, and ALAT levels were significantly higher. Conclusion: The average age was higher from 50 years old. These PLWHIVs were more frequently in WHO stage 4 with more common TB and anemia. Their Hb, HDL-C, and CD4s+ levels were lower while their urea, LDL-C and ALAT levels were significantly elevated.


Author(s):  
Rizwan Alimohammad ◽  
Sayed Tariq ◽  
Ali Elkharbotly ◽  
Ed Timm ◽  
Mikhail Torosoff

Background: NSAIDs may exert direct deleterious effects on CV system, while non-selective (NS) -NSAIDs may also diminish cardio-protective effect of low-dose aspirin. On another hand, NSAIDs may decrease CRP levels and ameliorate systemic inflammation. We have investigated short and long-term outcomes associated with NSAIDs use in post-PCI patients. Methods and Material: NSAID utilization, hospital and long-term outcomes of 2933 percutaneous coronary revascularizations (PCI) were collected and analyzed. Patients not on aspirin, or treated with rofecoxib and valdecoxib were excluded. ANOVA, Chi-square, Kaplan-Meyer analysis with log-rank test, and logistic regression were utilized. The study was approved by the Institutional IRB. Results: Patients treated with NS-NSAIDs, but not celecoxib, experienced longer length of stay, higher incidence of peri-procedural myocardial infarction, and mildly increased post-PCI mortality (Table). These effects were unchanged after adjustment for age (p=0.001), ejection fraction (p<0.001), and history of previous MI (p<0.001). There was a trend towards lower long-term (50+/-15 months) mortality in NS-NSAIDs (9%) and celecoxib (6.7%) treated patients, when compared to the rest of the cohort (11.3%, Table). Conclusion: Non-selective NSAIDs, but not Celecoxib, are associated with prolonged hospital stay and increased peri-procedural myocardial infarction in PCI patients. Long-term mortality does not appear to be affected by the NSAIDs use at the time of PCI. Randomized studies of this important clinical question are needed.


2008 ◽  
Vol 159 (4) ◽  
pp. 389-397 ◽  
Author(s):  
Annamaria Colao ◽  
Carolina Di Somma ◽  
Teresa Cascella ◽  
Rosario Pivonello ◽  
Giovanni Vitale ◽  
...  

BackgroundIn the general population, low IGF1 has been associated with higher prevalence of cardiovascular disease and mortality.ObjectiveTo investigate the relationships between IGF1 levels, blood pressure (BP), and glucose tolerance (GT).SubjectsFour-hundred and four subjects (200 men aged 18–80 years). Exclusion criteria: personal history of pituitary or cardiovascular diseases; previous or current treatments with drugs interfering with BP, GT, or lipids, corticosteroids (>2 weeks), estrogens, or testosterone (>12 weeks); smoking of >15 cigarettes/day and alcohol abuse (>3 glasses of wine/day).ResultsTwo hundred and ninety-six had normal BP (73.3%), 86 had mild (21.3%), and 22 had severe (5.4%) hypertension; 322 had normal GT (NGT (79.7%)), 53 had impaired glucose tolerance (IGT (13.1%)), 29 had diabetes mellitus (7.2%). Normotensive subjects had significantly higher IGF1 levels (0.11±0.94 SDS) than those with mild (−0.62±1.16 SDS, P<0.0001) or severe (−1.01±1.07 SDS, P<0.0001) hypertension. IGF1 SDS (t=−3.41, P=0.001) independently predicted systolic and diastolic BP (t=−2.77, P=0.006) values. NGT subjects had significantly higher IGF1 levels (0.13±0.90 SDS) than those with IGT (−0.86±1.14 SDS, P<0.0001) or diabetes mellitus (−1.31±1.13 SDS, P<0.0001). IGF1 SDS independently predicted fasting glucose (t=−3.49, P=0.0005) and homeostatic model assessment (HOMA)-R (t=−2.15, P=0.033) but not insulin (t=−1.92, P=0.055) and HOMA-β (t=−0.19, P=0.85).ConclusionIGF1 levels in the low normal range are associated with hypertension and diabetes in subjects without pituitary and cardiovascular diseases.


1987 ◽  
Author(s):  
M Monreal ◽  
E Lafoz ◽  
M Foz ◽  
J Monasterio

The acceptance of aspirin therapy for prevention of cerebral ischemia is based onpositive results of several large clinicaltrials, and the usual dose is 1000-1500 mg/day. Several recent reports emphasize the adverse effects of aspirin and other nonsteroidal anti-inflamatory agents on renal function. We examined wether two extreme doses of aspirin (60 mg vs 1200 mg/day) could alter renal function in patients recently admitted to hospital with cerebral ischemia. We studied 33 patients with cerebralischemia and no history of ingestion of aspirin nor other drugs two weeks prior to admission. During the first 5 days all patients received a 50 mEq sodium diet and no drugs, while during the second 5 days (trial) the patients were randomly assigned (double blind) to placebo, aspirin 20 mg or aspirin 400 mg, 3 times daily, with meals.Overall, body weight increased by 650 gin patients taking 1400 mg/day of aspirin (p≺0,01), but not in patients taking 60 mg/day. Also increases in systolic and diastolic blood pressure did not reach significant differences. While waiting morereports, aspirin at doses near 1000 mg should be administered cautiously in sodium restricted patients with cerebral ischemia.Acute water retention may be specially troublesome.


2019 ◽  
Vol 8 (1) ◽  
pp. 54-57
Author(s):  
Eva Santi Hutasoit ◽  
Yessi Azwar

Hypertension is a condition when blood pressure in blood vessels increases chronically (Suiraoka, 2012). The risk of increasing this blood pressure is related to race, family history of hypertension, obesity, diet / food intake, smoking and the length of time the combination hormonal contraceptive is used. Family acceptors who use hormonal contraception over a period of time often complain of health problems, one of the health problems that are often experienced by hormonal contraceptive acceptors is hypertension or high blood pressure. Hormonal contraception can cause high blood pressure (hypertension) in approximately 4-5% of women who have normal blood pressure before taking the drug, and can increase blood pressure in 9-16% of women who have suffered hypertension before. The type of research used in this study is quantitative, with analytic research design and with a cross sectional approach, namely research conducted simultaneously. The number of samples is 54 mothers who are KB KBtor. From the results of the study, it was found that respondents who used hormonal contraception experienced an increase in blood pressure by 37 people (84.1%), while those who did not experience a rise in blood pressure were 7 people (15.9%). Respondents who did not use hormonal contraception experienced an increase in blood pressure by 5 people (50.0%), while those who did not experience an increase in blood pressure were 5 people (50.0%). From the Chi-square test results obtained a value of 0,045 (Pvalue 0,045 <α 0,05) and OR 5,286. This shows that Ha is accepted which means that there is a relationship between the use of hormonal contraception and an increase in blood pressure. OR = 5,286 showed that the use of hormonal contraception 5 times was associated with increased blood pressure.


1981 ◽  
Vol 61 (s7) ◽  
pp. 359s-362s ◽  
Author(s):  
F. Wessels ◽  
D. Hoffmann ◽  
H. Wagner ◽  
H. Zumkley

1. The influence of family history of hypertension on the relationships between blood pressure, relative body weight, sodium/creatinine ratio of the 24 h urine, plasma renin activity and the plasma concentration of prolactin and parathormone were examined in 102 healthy male students. 2. Grouping together results from all students showed significant positive correlations between systolic blood pressure and prolactin, parathormone as well as relative body weight, between plasma renin activity and prolactin and a significant negative correlation between plasma renin activity and sodium/creatinine ratio of the 24 h urine. 3. By dividing the students into two groups according to their family history of hypertension we could demonstrate in those with family history of hypertension a highly significant positive correlation between mean blood pressure and sodium/creatinine ratio of the 24 h urine and an improvement of the correlations between systolic blood pressure and prolactin and between sodium/creatinine ratio of the 24 h urine and plasma renin activity. In students without family history of hypertension these relationships were no longer detectable. In the students without family history of hypertension the correlations between systolic blood pressure and relative body weight as well as between plasma renin activity and prolactin gained substantially in significance. In students with positive family history of hypertension these correlations could no longer be demonstrated. The correlations between systolic blood pressure and parathormone remained unaffected by family history of hypertension. 4. The results suggest that a genetic predisposition to essential hypertension is able to intensify the blood pressure effect of Na intake and of prolactin, which, besides its function as a sex hormone, is presumed additionally to be able to retain salt. However, the positive relationship between body weight and blood pressure, as well as between plasma renin activity and prolactin, the significance of which increases greatly in subjects without family history of hypertension, appears to be lost as the result of the increased sensitivity to salt in positive family history of hypertension.


2019 ◽  
Vol 6 ◽  
pp. 2333794X1982831
Author(s):  
Benjamin D. Kornfeld ◽  
Gal Finer ◽  
Laura E. Banks ◽  
Liliana Bolanos ◽  
Adolfo J. Ariza

Prematurity is a risk factor for elevated blood pressure (BP). We performed a mixed-methods study of care patterns and awareness of early BP screening recommendations for infants born prematurely (IBP) by interviewing/surveying providers on practice- and provider-level BP screening. IBP’s records were reviewed for BP screening documentation, demographics, and gestational age (GA). Visits <33 months were reviewed for anthropometrics, BP, and comorbidities. Chi-square analysis evaluated BP screening by GA and comorbidities. Twenty-six of 49 practices completed interviews; 81% had infant BP equipment available; 4% had BP measurement protocol for IBP. Twenty-eight of 86 providers were aware of screening guidelines; none reported routine assessment. Twenty-eight of 118 IBP had ≥1 BP documented; 43% had BP ≥90th percentile. Screening did not differ by GA group. Kidney-related diagnosis was associated with more frequent BP screening ( P = .0454). BP is not routinely measured though often elevated before age 3 in IBP.


1982 ◽  
Vol 63 (s8) ◽  
pp. 395s-398s ◽  
Author(s):  
Ove Andersson ◽  
Ramon Sivertsson ◽  
Rune Sannerstedt ◽  
Marie Beckman ◽  
Marie Magnusson ◽  
...  

1. Forty-four young men with blood pressure elevation and 29 age-matched volunteer subjects were examined with invasive blood pressure and cardiac output measurements. The regional blood flow resistance of the hand during hyperaemia was calculated from blood pressure and flow data from venous occlusion plethysmography. 2. In a re-examination 5 years later the same protocol was applied and an oral glucose tolerance test was performed with glucose and insulin determinations. Body composition was calculated from total body potassium data (whole body 40K counter) and body weight. 3. Patients with blood pressure elevation were characterized by a significantly higher cardiac index at rest, and a significantly increased resistance during hyperaemia of the hand in comparison with that of the controls. The patients with blood pressure elevations were also divided according to cardiac output. The hyper-kinetic subgroup did not have an increased resistance during hyperaemia. Patients with blood pressure elevation had significantly increased body weight and body mass index in comparison with controls and there was a significant correlation between body wieght and regional resistance during hyperaemia. 4. In the re-examination it was found that the body weight difference between patients with blood pressure elevation and normotensive controls was explained by increased body fat. There was no difference in body weight between the normokinetic and hyperkinetic subgroups of patients with blood pressure elevation but the former group had significantly increased insulin concentrations on the glucose load. 5. Significant correlations were demonstrated between body weight, body fat and insulin concentration 30 min after glucose load against resistance during hyperaemia as the dependent variable. A multiple regression coefficient of 0.59 was found between the three independent variables and resistance during hyperaemia. Furthermore, the addition of the insulin concentration variable to the two independent variables body weight and body fat increased significantly the multiple regression coefficient.


2002 ◽  
Vol 36 (4) ◽  
pp. 624-627 ◽  
Author(s):  
Beth Bryles Phillips ◽  
Jacqueline D Joss ◽  
Paul L Mulhausen

OBJECTIVE: To report a case of increased blood pressure associated with the use of salsalate in an elderly patient with no prior history of hypertension. CASE SUMMARY: A 78-year-old white man with no prior history of hypertension initiated salsalate therapy for low-back pain. Over the 15 months prior to the initiation of salsalate, his blood pressure averaged 127 ± 7 mm Hg systolic and 84 ± 6 mm Hg diastolic (mean ± SD). After initiation of salsalate, he experienced significant elevations in blood pressure, which led to a preliminary diagnosis of hypertension. Blood pressure after initiation of salsalate averaged 150 ± 13 mm Hg systolic and 95 ± 5 mm Hg diastolic. No changes in medications or medication doses (with the exception of warfarin) occurred in the 18 months prior to or during salsalate therapy. His weight remained stable. A detailed review of his medical records and history revealed no other causes for these elevations in blood pressure. Salsalate therapy was discontinued and his blood pressure returned to normotensive levels (119 ± 2 mm Hg systolic and 81 ± 2 mm Hg diastolic). DISCUSSION: Nonsteroidal antiinflammatory drug (NSAID)–induced elevations in blood pressure have been well documented in patients receiving antihypertensive medications. Due to its relative weak inhibition of cyclooxygenase and lack of published literature in hypertensive patients, salsalate is considered to have little or no effect on blood pressure. Our report documents a possible case of salsalate-induced hypertension in a previously normotensive elderly man. Observational studies suggest that NSAID use may increase the risk of developing hypertension in older patients. CONCLUSIONS: Clinicians should be aware of the possible effects of NSAIDs on blood pressure. Blood pressure monitoring following the initiation of salsalate may be warranted, particularly in older patients.


2017 ◽  
Vol 84 (4) ◽  
pp. 221-225 ◽  
Author(s):  
Pier A. Della Camera ◽  
Simone Morselli ◽  
Gianmartin Cito ◽  
Giovanni Tasso ◽  
Andrea Cocci ◽  
...  

Introduction Mediterranean diet has shown a protective role against cardiovascular disease, diabetes, cancer onset, microvascular damage and dementia in many trials. Our purpose is the assessment of a correlation between physical activity, Mediterranean diet, body mass index (BMI), depression and erection disorder (ED). Methods After having signed disclaimer to the study participation, we administered the IIEF 15 questionnaire (International Index of Erectil Function), the Hamilton questionnaire for major depression, the Med-Diet Questionnaire, the Ipaq Questionnaire (International Index of Physical Activity) to 245 patients and calculated the BMI. Only 141 were eligible. We excluded patients with a history of smoking, with obesity from the second grade to rise, anorexia, hyperlipidemia, Induratio Penis Plastica, diabetes, cardiovascular and neurological disease, hypogonadism, prostatitis, diabetes, hypertension, psychiatric diseases and the history of radical prostatectomy and finally age >72 and <50 years or who were taking cholesterol-lowering medication. Patients were divided into two groups: 65 patients without ED and 76 patients with ED. Results We found a statistically difference in BMI between the groups. Adherence to Med-Diet showed a significant difference between the two groups at Student t-test and the Chi-square test. The Ipaq test and Hamilton test did not show statistical differences between the two groups neither for Student t-test nor for Chi-square test, but high levels seem to be protective factors. Conclusions Body weight and a healthy diet are protective factors against the ED, more than a sufficient physical activity. Depression has shown only a worsening tendency of the erection.


Sign in / Sign up

Export Citation Format

Share Document